Jacklyn Stratton
Overview
Explore the profile of Jacklyn Stratton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Altwies H, Santacroce L, Marrugo J, Stratton J, Ellrodt J, Rudin R, et al.
ACR Open Rheumatol
. 2024 Dec;
7(1):e11768.
PMID: 39692736
Objective: Electronic health applications (apps) allow patients with rheumatoid arthritis (RA) to report patient-reported outcomes (PROs) between visits. However, almost no data exist on patients' report of pain between visits...
2.
Solomon D, Altwies H, Santacroce L, Ellrodt J, Pham T, Stratton J, et al.
Arthritis Rheumatol
. 2023 Dec;
76(5):677-683.
PMID: 38087859
Objective: Patient-reported outcome (PRO) collection between visits for rheumatoid arthritis (RA) could improve visit efficiency, reducing in-person visits for patients with stable symptoms while facilitating access for those with symptoms....
3.
Zhang H, McDermott G, Seyok T, Huang S, Dahal K, LYi S, et al.
EBioMedicine
. 2023 Apr;
92:104581.
PMID: 37121095
Background: Rheumatoid arthritis (RA) shares genetic variants with other autoimmune conditions, but existing studies test the association between RA variants with a pre-defined set of phenotypes. The objective of this...
4.
Tedeschi S, Solomon D, Chen Y, Ellrodt J, Whelan M, Stratton J, et al.
Semin Arthritis Rheum
. 2023 Feb;
59:152177.
PMID: 36796211
Objective: Disease-modifying anti-rheumatic drugs (DMARDs) that treat rheumatoid arthritis (RA) may reduce immune responses to COVID-19 vaccination. We compared humoral and cell-mediated immunity before and after a 3rd dose of...
5.
Ellrodt J, Pincus T, Shadick N, Stratton J, Santacroce L, Katz J, et al.
J Clin Rheumatol
. 2022 May;
28(5):265-269.
PMID: 35612561
Objective: Limited information is available concerning experiences of participants in a virtual learning collaborative (LC), and little qualitative data or participant feedback on how this format can be improved. One...
6.
Tedeschi S, Stratton J, Ellrodt J, Whelan M, Hayashi K, Yoshida K, et al.
Ann Rheum Dis
. 2022 Feb;
81(7):1045-1048.
PMID: 35168944
No abstract available.
7.
Solomon D, Pincus T, Shadick N, Stratton J, Ellrodt J, Santacroce L, et al.
Arthritis Care Res (Hoboken)
. 2022 Feb;
74(4):572-578.
PMID: 35119779
Objective: A treat-to-target (TTT) approach improves outcomes in rheumatoid arthritis (RA). In prior work, we found that a learning collaborative (LC) program improved implementation of TTT. We conducted a shorter...
8.
Tedeschi S, Ellrodt J, Stratton J, Santacroce L, Chandler P, Gravallese E, et al.
ACR Open Rheumatol
. 2021 Oct;
4(1):3-7.
PMID: 34613668
Objective: Vaccination against preventable infections is widely recommended for patients with systemic rheumatic disease. The coronavirus disease 2019 (COVID-19) pandemic has highlighted variability in attitudes toward vaccination, particularly with the...
9.
Johansson F, Collins J, Yau V, Guan H, Kim S, Losina E, et al.
J Rheumatol
. 2021 May;
48(9):1364-1370.
PMID: 33934070
Objective: Tocilizumab (TCZ) has shown similar efficacy when used as monotherapy as in combination with other treatments for rheumatoid arthritis (RA) in randomized controlled trials (RCTs). We derived a remission...
10.
Huang S, Huang J, Cai T, Dahal K, Cagan A, He Z, et al.
Rheumatology (Oxford)
. 2020 May;
59(12):3759-3766.
PMID: 32413107
Objective: The objective of this study was to compare the performance of an RA algorithm developed and trained in 2010 utilizing natural language processing and machine learning, using updated data...